What's Powering Johnson & Johnson's Impressive Quarterly Earnings?
Johnson & Johnson (NYSE: JNJ) surprised investors with better-than-hoped-for top-line and bottom-line performance in the third quarter, and that news sent shares soaring on Tuesday. The company's revenue and profit growth were supported by acquisitions, but even after factoring out the positive impact of deals, the financial results were still impressive. Here's what's behind J&J's strong quarter and what the future may have in store for this Dividend Aristocrat.
Johnson & Johnson markets consumer goods, pharmaceuticals, and medical devices, and in the third quarter, sales in each of these segments were higher than Q3 2016.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Johnson & Johnson Stock
€135.60
0.120%
The stock is one of the favorites of our community with 32 Buy predictions and 1 Sell predictions.
With a target price of 195 € there is a positive potential of 43.81% for Johnson & Johnson compared to the current price of 135.6 €.
